Hinge Health, Inc.: Barclays raises target price to $110 from $100
HNGE•Barclays raised its price target for Hinge Health to $110 from $100.
Related News
TFI International price objective cut to $164 from $187
TFII•
Avery Dennison appoints Helen Sheirbon president of Solutions Group
AVY•
Vera Therapeutics receives market perform rating with $34 target
VERA•
Nektar Therapeutics: Leerink Partners initiates coverage with outperform rating; target price $130
NKTR•
Houlihan Lokey, Inc.: BofA Global Research cuts price objective to $150 from $152
HLI•